Brandy Ford, SVP and Chief Accounting Officer of ScanSource, Inc. (NASDAQ:SCSC), filed a Form 4 on September 4, 2026, reporting the sale of a combined 5,293 shares of common stock in two separate transactions on the same date.
Jennifer Bush, Chief Operating Officer, Chief Legal Officer, and Compliance Officer of Artiva Biotherapeutics, Inc., filed a Form 4 on September 4, 2026, reporting a sale of common stock on September 3, 2026, executed automatically under the company's sell-to-cover policy to satisfy tax withholding …
Christopher Horan, Chief Tech Operations Officer of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), filed a Form 4 on September 4, 2026, reporting the sale of common stock on September 3, 2026, in connection with the vesting of restricted stock units.
Katherine Gill Charest, Executive Vice President, Controller and Chief Accounting Officer of Paramount Skydance Corp, filed a Form 4 on September 4, 2026, disclosing transactions in Class B common stock on September 2, 2026, stemming from the vesting of Restricted Stock Units.
George Boyan, President and Director of Unity Bancorp Inc /NJ/ (NASDAQ:UNTY), filed a Form 4 on September 4, 2026, disclosing the sale of common stock across two trading days in early September 2026.
Beta Bionics, Inc. President and CEO Sean Saint filed a Form 4 on September 4, 2026, disclosing the sale of 5,641 shares of common stock on September 3, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
Seth A. Ravin, President, CEO, and Chairman of Rimini Street, Inc. (NASDAQ:RMNI), filed a Form 4 on September 4, 2026, disclosing the sale of 322,707 shares of common stock across three consecutive trading days through the SAR Trust.
Kenneth B. Bement, Chief Accounting Officer of Trimble Inc. (NASDAQ:TRMB), filed a Form 4 on September 4, 2026 reporting transactions dated September 2, 2026, including the vesting of restricted stock units and a related share withholding.
Amar K. Goel, Chairman and Chief Innovation Officer of PubMatic, Inc., filed a Form 4 on September 4, 2026, reporting transactions in Class A Common Stock dated September 3, 2026, on NASDAQ:PUBM.
Mark S. Livingston, Chief Financial Officer of Progyny, Inc. (NASDAQ:PGNY), filed a Form 4 on September 4, 2026, disclosing two disposals of common stock on September 2 and September 3, 2026, related to the vesting of restricted stock units.